The new and improved tool, created by a first-year hematology and oncology fellow Samuel Short, MD, at the UNC School of Medicine, can help physicians better assess stroke risk in people with atrial fibrillation.

A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug significantly reduces cardiovascular events in people with type 2 diabetes, pre-existing cardiovascular disease, and/or chronic kidney disease.

Researchers pinpoint small molecules that greatly affect differences in heart health in men and women.

A research team led by Priya Palta, PhD, MHS, an associate professor of neurology at the UNC School of Medicine, has found that certain Alzheimer’s disease and neurodegenerative blood biomarkers in midlife and late life had strong associations with late-life dementia.

John P. Vavalle, MD, MHS, FACC, and Matthew A. Cavender, MD, MPH, FACC, interventional cardiologists and their collaborative team in the Structural Heart Disease Program at UNC, have performed their first transcatheter tricuspid valve replacement in the clinical setting, a revolutionary treatment for patients living with a common type of heart valve disease.

In this new Vital Signs series, we feature graduate student Autumn Grace Hullings in the Gordon-Larsen lab. Inspired by the emerging field of precision nutrition, Hullings would like to improve dietary guidelines to prevent or reduce cardiometabolic disease.

UNC School of Medicine scientists Whitney Edwards, PhD, Frank Conlon, PhD, and colleagues identified molecular pathways critical for heart development.

Brian C. Jensen, associate professor of medicine and pharmacology in the Department of Medicine’s Division of Cardiology, speaks about his research on kinase inhibitor cardiotoxicity.

The UNC Gillings School of Global Public Health and Wake Forest School of Medicine will lead a $29.9 million effort to help stroke survivors prevent another stroke by controlling blood pressure.

Publishing their work in Nature, UNC School of Medicine researchers led by Li Qian, PhD, show how their new research platform helped them discover new cell subpopulations and crucial cellular players in the process of turning damaged heart tissue back into healthy heart muscle. The research platform could be used to study other biological processes and create tailored therapies.

One laboratory method to create healthy heart muscle leads to better organized sarcomeres -- the cells that make heart muscle striated.

For the first time, UNC scientists detail crucial differences in two leading methods for generating heart muscle cells, a key strategy for new post-heart attack therapies.

Jessica Riley, a patient in the UNC Wound Healing Center took part in a clinical trial for venous leg ulcers

Patient Jessica Riley was referred to the UNC Wound Healing Center, part of the UNC Center for Heart and Vascular Care, for her venous leg ulcer and entered a clinical trial led by William Marston, MD **Graphic images included**

Tag: Heart Disease

New Calculator to Better Predict Stroke Risk in Atrial Fibrillation Patients

Study Finds Oral Semaglutide Vastly Reduces Heart Attacks, Strokes

MicroRNA Responsible for Sex Differences in Cardiac Physiology, Disease

Researchers Link Midlife Blood Biomarkers to Late-life Dementia Risk

UNC Hospitals Performs First Transcatheter Tricuspid Valve Replacement in North Carolina

Five Questions with Autumn Grace Hullings

Researchers Target Proteins, Pathways Behind Congenital Heart Disease

Getting to the Heart of Chemotherapeutic Cardiotoxicity

‘Stroke Belt’ battle: $30M study from UNC, Wake Forest targets blood pressure

How to Turn Damaged Heart Tissue Back into Healthy Heart Muscle: New Details Emerge

Post Heart Attack: How can scar tissue be turned back into healthy heart muscle?

After suffering from open wound for almost two years, patient in UNC Center for Heart and Vascular heals in a matter of weeks as participant in clinical trial